Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

OXYTOCIN Drug Profile

« Back to Dashboard

Which patents cover Oxytocin, and what generic Oxytocin alternatives are available?

Oxytocin is a drug marketed by Hikma Farmaceutica, West-ward Pharms Int, Fresenius Kabi Usa, Teva Pharms Usa, and Abbott. and is included in five NDAs.

The generic ingredient in OXYTOCIN is oxytocin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the oxytocin profile page.

Summary for Tradename: OXYTOCIN

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list5
Bulk Api Vendors: see list25
Clinical Trials: see list151
Patent Applications: see list6,220
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYTOCIN at DailyMed

Pharmacology for Tradename: OXYTOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica
OXYTOCIN
oxytocin
INJECTABLE;INJECTION200219-001Feb 13, 2013APRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
OXYTOCIN
oxytocin
INJECTABLE;INJECTION077453-001Jan 24, 2008DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
OXYTOCIN
oxytocin
INJECTABLE;INJECTION018248-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Abbott
OXYTOCIN 5 USP UNITS IN DEXTROSE 5%
oxytocin
INJECTABLE;INJECTION019185-001Mar 29, 1985DISCNYesNo► Subscribe► Subscribe
Teva Pharms Usa
OXYTOCIN
oxytocin
INJECTABLE;INJECTION077453-002Jan 24, 2008DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot